Open in interactive viewer → charts, metric popovers & call review

Summit Midstream Finally Delivers — and Quietly Announces the Bill

A 30% Rockies CAGR, a dividend 'just around the corner,' a capex step-change management only began telegraphing this quarter, and a sudden retreat from the M&A playbook
SMC · Earnings Call · 2026-11-10

Three years of promises, one quarter of proof

Summit Midstream is a $385 million micro-cap that has spent years telling investors about an organic growth story while the stock did very little to corroborate it. The shares are down 18% since mid-2024 and sit 33% below their February 2025 peak of $45.21, and the last 90 sessions have been a flatline. So the third quarter mattered less for the headline than for the corroboration: adjusted EBITDA of $70.7 million, up 16% sequentially, and a guidance raise to $250–260 million from $235–255 million. “we are raising our full year 2026 adjusted EBITDA guidance to a range of $250 million to $260 million, which is up from $235 million to $255 million previously” — J. Deneke, Chief Executive Officer · 2026-11-10 The engine was the Rockies segment, where 51 wells were connected across the Williston and DJ, liquids throughput jumped nearly 40% quarter-over-quarter to 95,000 barrels a day, and segment EBITDA rose $9.6 million to $40 million. Management's framing is that the new wells have added roughly $16.5 million of quarterly EBITDA since the first quarter — about 30% growth in two quarters — with 7 rigs running behind the system and a DUC inventory of roughly 140. The fundamental data through the prior quarter shows the operating leverage starting to show up in the income statement at last: total revenue of $155 million in the June quarter was up 11% year-over-year, and operating income flipped back to a small positive after a brutal 2024–25 stretch that included a $205 million net loss quarter.

The growth is real; the capex is the asterisk

The problem with a story this good is that it requires steel, compression and pipe. Heath Deneke now guides to a mid- to high-teens adjusted EBITDA CAGR over the next several years, with as much as a 30% CAGR in Rockies EBITDA over the next two years as producers migrate from McKenzie County into Williams and Divide County, fill the DJ processing plants by the end of 2027, and push for a brownfield expansion at Jackson Lake. In the Permian, the mainline compression expansion takes Double E to 2.4 Bcf/d and, per management, pushes segment EBITDA from roughly $40 million this year to over $100 million by 2029. That Permian number is a quiet upgrade. In May, the same CEO described the trajectory as growing "from roughly 35 up to the mid-$60 millions here just with what we have contracted to date... and then if you look at, you know, with the expansion that we have announced, we think that could grow up to $90 million." “we see our EBITDA growing, you know, from roughly 35 up to the mid-$60 millions here just with what we have contracted to date” — J. Heath Deneke, President and Chief Executive Officer · 2026-05-12 Nine months later the target is $100 million-plus. That is a genuine, contract-backed escalation rather than a re-based slide. The bill arrives in the same breath. “We're looking at $130 million to $140 million of capital net to Summit. So think about that as for $60 million of contracted EBITDA growth, a fairly attractive build multiple.” — William Mault, Chief Financial Officer · 2026-11-10 That build multiple math is genuinely attractive — roughly 2.3x — but it is capital that flows out before the EBITDA flows in, and it lands on top of a base business whose capital expenditure was already $25 million in the June quarter and is guided to $100–120 million for the full year. Management concedes 2027 could see "some facility expansion capital kind of bump up," framing the organic growth projects as customer-push initiatives earning north of 20% unlevered returns. Investors should treat the mid-teens CAGR headline as gross of a capex cycle they have not yet quantified.

The dividend pivot — and the Piceance hole underneath it

Leverage is the tell. Net leverage was 3.9x at quarter-end and is expected to hit approximately 3.6x by year-end, against a long-stated target of 3.5x. On the August call, Deneke put the timeline at "the next 12 to 18 months"; three months later the language has sharpened to a Board decision in early 2027. “I would expect us to really start considering a dividend policy towards early next year... we want to make sure that we don't start out too big and whatever we do put out there, we can sustain forever and have a lot of room to grow it.” — J. Deneke, Chief Executive Officer · 2026-11-10 A deliberately small inaugural distribution is the right instinct for a company still carrying roughly $1.2 billion of effective net debt. What was less emphasized: the Piceance MVC shortfall payments expired at the end of the third quarter, and they contributed $4.1 million of segment EBITDA in Q3. “Those mechanisms contributed $4.1 million of adjusted EBITDA in the third quarter. So that's something to keep in mind as you think about that segment going forward.” — William Mault, Chief Financial Officer · 2026-11-10 This was flagged in August — “you should expect a step down in cash flow starting in the fourth quarter... there is roughly $4 million of shortfall payments a quarter” — William J. Mault, Chief Financial Officer · 2026-08-11 — so it is a known, pre-announced hole rather than a surprise. But it means the Q4-to-Q1 run-rate bridge has a five-point headwind baked in that the guidance raise obscures.

The most interesting thing: Summit stops being a buyer

Summit's keyword history is littered with acquisitions — Moonrise, Tall Oak, and quarters of talk about bolt-ons in the Rockies at 5x to 7x. This quarter the keyword M&A front ranked near the top of the company's own momentum list, yet the message inverted completely. In August, Deneke was still pitching the Rockies as the place to buy, saying "we participated in some process that we stayed disciplined and let some assets go." “we have got a lot of organic growth ahead... we have seen some M&A get a little frothy, frankly.” — J. Heath Deneke, President and CEO · 2026-08-11 By November, the CFO had turned that into an explicit stand-down.

we're seeing asset level deals, some of which are single customer, one basin type transactions that are getting done at north of 8x pre-G&A EBITDA. And when we're trading sub 8x post G&A, it just doesn't add up... I think you should expect that we'll probably slow down on the M&A front.

William Mault, Chief Financial Officer · 2026-11-10
That is the single most self-aware sentence on the call, and it is also the crux of the investment case. The stock trades at 0.3x revenue, down 65% from 0.9x two years ago — a valuation that says the market does not believe the growth guidance. If Summit can convert a mid-teens organic CAGR, a below-3.5x balance sheet and a starter dividend into institutional relevance, that multiple is the return. If the capex cycle eats the free cash flow — Q3 free cash flow was only $5.2 million against $32.6 million of distributable cash flow — the discount persists.

The verdict

There is genuine momentum here: lateral lengths extending from two miles to four are lowering customer breakevens, and the emerging Arkoma dry-gas window — three wells at roughly 50 million a day — is an optionality nobody is paying for. But the confluence with peers is instructive rather than exciting: brownfield expansions and Permian egress are the lingua franca of every midstream call this season, and Summit is a small participant in a well-trodden narrative. What is company-unique is the abrupt refusal to buy growth at 8x while its own equity trades below that. That is a management team betting its re-rating on organic execution and a dividend, and it is the first time in several quarters the story has been truly falsifiable.